Archiwum hase³
tau protein pathology | epicondyle | lateral epicondyle | thighbone | infectiology | Pick’s disease | tauopathy | organic aciduria | organic acidemia | peroxisomes | acute fatty liver of pregnancy {AFLP} | carnitine cycle | carbohydrate antigen | proenzymes of matrix metalloproteinases {proMMPs} | tissue inhibitors of metalloproteinases {TIMPs} | epitope | antigenic determinant | galactosyltransferase | xenotransplant | germ-cell tumors | dermoid cysts | cyclins | blood-retina barrier | mitochondrial membranes | pseudogene | synaptic degeneration | traveler's diarrhoea | activation-induced cell death {AICD} | calcaneal apophysitis | carcinoembryonic antigen {CEA} | endopeptidases | membrane type metalloproteinases | fly-wheel | hairspin | osteolysis | follicular dendritic cell-derived receptor | bone metastasis-related factor | macrophage inflammatory protein | osteoclast differentiation factor | osteoprotegerin {OPG} | ligand osteoprotegeryny | oncostatin M {OSM} | prostate-specific antigen {PSA} | receptor activator of nuclear factor NF-kB {RANK} | receptor activator | receptor activator of nuclear factor NF-kB ligand {RANKL} | RANK ligand | soluble RANKL {sRANKL} | tumor necrosis factor receptor {TNFR} | urokinase plasminogen activator {uPA} | tumor osteolysis | osteoclasts | osteoblast | translatability | germ line | anti-lice shampoo | patella tendonitis | jumper\'s knee | Sinding-Larsen-Johansson disease | hyponatremia | cardiac troponin I gene | fatty acid binding protein | multigated radionuclide angiography | antineoplastic chemotherapy | cardiac troponins | complementary DNA {cDNA} | horseradish peroxidase {HRP} | intracellular cytokine staining {ICS} | limiting dilution assay {LDA} | pokeweed mitogen | hormone-like proteins | immunohistochemical staining | dihydrorhodamine | hyaluronan | chemiluminescence method | flow cytometric method | intracellular oxygen potential | jumper's knee | peritoneal fibrosis | peritoneal membrane | glucose degradation products | mesothelial cells | outer membrane proteins | molecular mimicry | enolase | phosphopyruvate dehydratase | enolase-like protein | metalloenzyme | specific diagnostic marker | epigenetic codes | histone modifications | endothelial cell sprouting | pericytes | Rouget cells | adventitial cells | mural cells | intussusceptive angiogenesis | glomerular angiogenesis | glomeruloid angiogenesis | caffeic acid phenethyl ester {CAPE} | daunorubicin {DNR} | daunorubicinol {DNRol} | doxorubicinol | tomato extract | grape seed extract | inhibitory concentration {IC}(50%) | idarubicin | idarubicinol | lactate dehydrogenase {LDH}, {LD} | lycopene | monohydroxyethylrutosides | 4-phenyl-2-propionamidotetralin (4P-PDOT) | N-acetylcysteine | 6-hydroxymelatonin | p-coumaric acid | salvianolic acids | thiobarbituric acid reactive substances {TBARS} | chalcone | leukemia inhibitory factor {LIF} | stroke volume {SV} | histone modifications | Löfgren`s syndrome | spinach extract | floor plate | somite | myelencephalon | disease status | efflux pump inhibitors {EPI} | multi antibiotic resistance {MAR} | penicillin binding protein{PBP} | dendritic epidermal T cells {DETC} | neurokinin receptors | hematopoietic cells | myelofibrosis | myeloid metaplasia, , | chronic idiopathic myelofibrosis | osteomyelofibrosis | primary myelofibrosis | myelofibrosis with myeloid metaplasia | agnogenic myeloid metaplasia | myxedema coma | ejection fraction | relapsing multiple sclerosis | squamous cell carcinoma antigen {SCCA} {SSC-Ag} {SSC} | tissue polypeptide antigen {TPA} | telomerase | cervical carcinoma | cyclic guanosine monophosphate {cGMP} | monotreme | peripartum cardiomyopathy | cytosine methylation | oro-pharyngeal | Schwabachs test | ocrelizumab | multifocal leukoencephalopathy | double-strand breaks {DSBs} | phosphoinositide 3-kinase | nuclear localization sequences {NLS} | DNA binding domain | stress-activated protein kinases {SAPK} | guanosine triphosphate {GTP} | imatinib mesylate {IM} | complete hematologic response {CHR,} | cytogenetic response | complete cytogenetic response | major cytogenetic response {MCyR} | complete molecular response {CmolR} | molecular response | myeloproliferative neoplasms | nuclear export signal | Abelson leukemia | chromoendoscopy | Juvenile osteochondrosis of second metatarsus | Löfgren syndrome | cytidine deaminase | exposed uninfected {EU} | exposed seronegative {ESN} | highly exposed, persistently seronegative {HEPS} | highly active antiretroviral therapy | elite controllers {EC} | aviremic controllers {AC} | human T-cell leukemia virus type 1 {HTLV-1 1} | intravenous drug users {IDU} | long term nonprogressors {LTNPs} | mannose binding lectins {MBL} | peripheral blood mononuclear cells {PBMC} | RNAinduced silencing complex {RISC} | rapid progressors {RP} | simian immunodeficiency virus SIV | African Green Monkey virus | killer cell immunoglobulin-like receptors {KIR} | slow progressors {SP} | tick-borne encephalitis virus {TBEV} | West Nile virus | genes coding proteins | cyclophilin | apoptosis signal-regulating kinase 1 {ASK} | extracellular signal-regulated kinases {ERK} | c-Jun-terminal kinase {JNK} | cell adaptation |
Poprzednia 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 Nastêpna
